Dimed S A Distribuidora de Medicamentos : Comunicado ao Mercado
August 11, 2022 at 11:27 am EDT
Share
2Q22 Results
#TodoCuidadoAoCuidar
Retail Gross
Revenue
R$ 965M (+25.9%)
Group Gross
Revenue
R$ 1,058M (+26.7%)
HIGHLIGHTS
2Q22
Retail Gross
Adjusted
Market
Margin
EBITDA
Share
31.1% (+0.9 p.p.)
R$ 56M (+40.7%)
+ 0,4 p.p.
Margin of 5.3%
(vs 2Q21)
Digital
Stores opening
NPS
15.7% of Sales
+ 17 New stores
80
(+24.1% vs 2Q21)
2
CONSISTENT GROWTH
Evolution - Retail Gross Revenue
R$ 3.174
R$ 2.692
CAGR
R$ 2.541
R$ 2.252
+22.6%
2Q19/2Q22
16.8%
R$ 2.058
R$ 1.819
R$ 1.843
CAGR 14%
R$ 1.558
R$ 1.503
R$ 1.368
CAGR
R$ 1.217
R$ 1.040
1H19/1H22
R$ 874
15.5%
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
1H21
1H22
3
RETAIL GROSS REVENUE WITH EXCELLENT PERFORMANCE VS 2Q21, ON A
STRONG COMPARISON BASIS
Sales Growth - Retail
Panvel's sale grows 25.9% in 2Q22
(R$ millions)
Gross Revenue - Retail
883.9
877.4
965.4
766.8
787.9
2Q21
3Q21
4Q21
1Q22
2Q22
28.9%
25.9%
18.1%
19.3%
14.3%
2Q21
3Q21
4Q21
1Q22
2Q22
Panvel Average Sale - Southern Region
Growth 2Q22 vs 2Q21
Average sale
Panvel 2Q22
12.9%
R$ 598k
6.5%
4.1%
Panvel
Abrafarma
Chains
Fonte: IQVIA
4
MSSS AND SSS SHOW ROBUST GROWTH AND ABOVE INFLATION IN 2Q22
Same Stores Growth
19.9%
19.2%
10.6%
11.8%
8.4%
2Q21
3Q21
4Q21
1Q22
2Q22
MSSS GROWS 15.8% IN THE
QUARTER
GROWS 19.2% IN THE QUARTER
Mature Stores Growth
16.7%
15.8%
10.3%
7.9%
6.4%
2Q21
3Q21
4Q21
1Q22
2Q22
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Dimed SA Distribuidora de Medicamentos published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 15:26:03 UTC.
Dimed SA Distribuidora de Medicamentos, formerly Panvel SA Drogarias e Farmacias, is a Brazil-based company principally engaged in the sale of drugs. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. It organizes its business into two main segments: Medicine and Perfumery. The Company provides retail and wholesale distribution. The Company owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.